Transfusion-transmitted babesiosis in the United States: Summary of a workshop

Transfusion

Volumn 49, Issue 12, 2009, Pages 2759-2771

  Kumar, Sanjai ^a   Gubernot, Diane M ^a   Nakhasi, Hira L ^a   Mied, Paul A ^a   Asher, David M ^a   Epstein, Jay S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PARASITE ANTIBODY;

ALGORITHM; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; BABESIA; BABESIOSIS; BLOOD DONOR; BLOOD EXAMINATION; BLOOD TRANSFUSION; BORRELIA BURGDORFERI; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE TRANSMISSION; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; LIFE CYCLE; NONHUMAN; PARASITE IMMUNITY; PARASITE VECTOR; PATHOGENESIS; RISK ASSESSMENT; SEROLOGY; UNITED STATES;

BABESIA; BABESIOSIS; BLOOD TRANSFUSION; HUMANS; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 71849102558     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02429.x     Document Type: Conference Paper

References (30)

1. Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang 2006 90 : 157 65.
2. Gubernot DM, Lucey CT, Lee KC, Conley GB, Holness LG, Wise RP. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis 2009 48 : 25 30.
3. Krause PJ, Spielman A, Telford SR 3rd., Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH. Persistent parasitemia after acute babesiosis. N Engl J Med 1998 339 : 160 5.
4. Leiby DA, Chung AP, Gill JE, Houghton RL, Persing DH, Badon S, Cable RG. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion 2005 45 : 1804 10.
5. Conrad PA, Kjemtrup AM, Carreno RA, Thomford J, Wainwright K, Eberhard M, Quick R, Telford SR 3rd., Herwaldt BL. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 2006 36 : 779 89.
6. Herwaldt B, Persing DH, Precigout EA, Goff WL, Mathiesen DA, Taylor PW, Eberhard ML, Gorenflot AF. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996 124 : 643 50.
7. Herwaldt BL, Caccio S, Gherlinzoni F, Aspöck H, Slemenda SB, Piccaluga P, Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Löschenberger K, Tura S, Pieniazek NJ. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 2003 9 : 942 8.
8. Kim JY, Cho SH, Joo HN, Tsuji M, Cho SR, Park IJ, Chung GT, Ju JW, Cheun HI, Lee HW, Lee YH, Kim TS. First case of human babesiosis in Korea: detection and characterization of a novel type of Babesia sp. (KO1) similar to bovine babesia. J Clin Microbiol 2007 45 : 2084 7.
9. Cangelosi JJ, Sarvat B, Sarria JC, Herwaldt BL, Indrikovs AJ. Transmission of Babesia microti by blood transfusion in Texas. Vox Sang 2008 95 : 331 4.
10. Goethert HK, Telford SR 3rd. Enzootic transmission of Babesia divergens among cottontail rabbits on Nantucket Island, Massachusetts. Am J Trop Med Hyg 2003 69 : 455 60.
11. Krause PJ, McKay K, Gadbaw J, Christianson D, Closter L, Lepore T, Telford SR 3rd., Sikand V, Ryan R, Persing D, Radolf JD, Spielman A Tick-Borne Infection Study Group. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 2003 68 : 431 6.
12. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001 32 : 1117 25.
13. Vannier E, Borggraefe I, Telford SR 3rd., Menon S, Brauns T, Spielman A, Gelfand JA, Wortis HH. Age-associated decline in resistance to Babesia microti is genetically determined. J Infect Dis 2004 189 : 1721 8.
14. Eberhard ML, Walker EM, Steurer FJ. Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. J Parasitol 1995 81 : 790 2.
15. Mintz ED, Anderson JF, Cable RG, Hadler JL. Transfusion-transmitted babesiosis: a case report from a new endemic area. Transfusion 1991 31 : 365 8.
16. Food and Drug Administration. Guidance for industry. Biological product deviation reporting for blood and plasma establishments. 2006. Available from: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm073455.htm
17. Food and Drug Administration. Guidance for industry. Notifying FDA of fatalities related to blood collection or transfusion. 2003. Available from: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm074947.htm
18. Barbour AG, Jasinskas A, Kayala MA, Davies DH, Steere AC, Baldi P, Felgner PL. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun 2008 76 : 3374 89.
19. Chisholm ES, Ruebush TK 2nd., Sulzer AJ, Healy GR. Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 1978 27 : 14 9.
20. Krause PJ, Telford SR 3rd., Ryan R, Conrad PA, Wilson M, Thomford JW, Spielman A. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis 1994 169 : 923 6.
21. Ryan R, Krause PJ, Radolf J, Freeman K, Spielman A, Lenz R, Levin A. Diagnosis of babesiosis using an immunoblot serologic test. Clin Diagn Lab Immunol 2001 8 : 1177 80.
22. Loa CC, Adelson ME, Mordechai E, Raphaelli I, Tilton RC. Serological diagnosis of human babesiosis by IgG enzyme-linked immunosorbent assay. Curr Microbiol 2004 49 : 385 9.
23. Krause PJ, Telford S 3rd., Spielman A, Ryan R, Magera J, Rajan TV, Christianson D, Alberghini TV, Bow L, Persing D. Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. J Clin Microbiol 1996 34 : 2791 4.
24. Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR. Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis 2003 9 : 184 8.
25. Grellier P, Benach J, Labaied M, Charneau S, Gil H, Monsalve G, Alfonso R, Sawyer L, Lin L, Steiert M, Dupuis K. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 2008 48 : 1676 84.
26. Castro E, Girones N, Bueno JL, Carrion J, Lin L, Fresno M. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 2007 47 : 434 41.
27. Hardwick CC, Herivel TR, Hernandez SC, Ruane PH, Goodrich RP. Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology. Photochem Photobiol 2004 80 : 609 15.
28. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005 45 : 1335 41.
29. Ambruso DR, Marschner S, Goodrich RP. Lack of antibody formation in platelet neoantigens after transfusion of Mirasol treated platelets concentrates. Transfusion. In press 2009.
30. Goodrich R, Roberts T, Follea G. Clinical evaluation of Mirasol PRT treated apheresis platelets in thrombocytopenic patients. Transfusion 2008 48 : 20A.